Adherens junctional associated protein-1: A novel 1p36 tumor suppressor candidate in gliomas (Review)

Zeng,Liang; Fee,Brian E.; Rivas,Miriam V.; Lin,James; Adamson,David Cory

doi:10.3892/ijo.2014.2425

Adherens junctional associated protein-1: A novel 1p36 tumor suppressor candidate in gliomas (Review)

Authors:
- Liang Zeng
- Brian E. Fee
- Miriam V. Rivas
- James Lin
- David Cory Adamson
View Affiliations

Affiliations: Department of Neurosurgery, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, P.R. China, Department of Surgery (Neurosurgery), Duke University Medical Center, Durham, NC, USA
Published online on: May 8, 2014 https://doi.org/10.3892/ijo.2014.2425
Pages: 13-17

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In a broad range of human cancers 1p36 has been a mutational hotspot which strongly suggests that the loss of tumor suppressor activity maps to this genomic region during tumorigenesis. Adherens junctional associated protein-1 (AJAP1; also known as Shrew1) was initially discovered as a novel transmembrane protein of adherent junctions in epithelial cells. Gene profiling showed AJAP1 on 1p36 is frequently lost or epigenetically silenced. AJAP1 may affect cell motility, migration, invasion and proliferation by unclear mechanisms. AJAP1 may be translocated to the nucleus, via its interaction with β‑catenin complexes, where it can regulate gene transcription, then possibly have a potent impact on cell cycling and apoptosis. Significantly, loss of AJAP1 expression predicts poor clinical outcome of patients with malignant gliomas such as GBM and it may serve as a promising tumor suppressor-related target. In this review, we summarize and discuss current knowledge that may identify AJAP1 as a tumor suppressor in gliomas.

View Figures

View References

1.	Caron H, Spieker N, Godfried M, et al: Chromosome bands 1p35–36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted. Genes Chromosomes Cancer. 30:168–174. 2001.
2.	Godfried MB, Veenstra M, Valent A, et al: Lack of interstitial chromosome 1p deletions in clinically-detected neuroblastoma. Eur J Cancer. 38:1513–1519. 2002. View Article : Google Scholar : PubMed/NCBI
3.	Felsberg J, Erkwoh A, Sabel MC, et al: Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival. Brain Pathol. 14:121–130. 2004. View Article : Google Scholar : PubMed/NCBI
4.	Bagchi A, Papazoglu C, Wu Y, et al: CHD5 is a tumor suppressor at human 1p36. Cell. 128:459–475. 2007. View Article : Google Scholar : PubMed/NCBI
5.	Piaskowski S, Rieske P, Szybka M, et al: GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis. Cancer Genet Cytogenet. 162:63–67. 2005. View Article : Google Scholar : PubMed/NCBI
6.	Edström Elder E, Nord B, Carling T, et al: Loss of heterozygosity on the short arm of chromosome 1 in pheochromocytoma and abdominal paraganglioma. World J Surg. 26:965–971. 2002.
7.	Bieche I, Khodja A and Lidereau R: Deletion mapping of chromosomal region 1p32-pter in primary breast cancer. Genes Chromosomes Cancer. 24:255–263. 1999. View Article : Google Scholar
8.	Cheung TH, Lo KW, Yim SF, et al: Clinicopathologic significance of loss of heterozygosity on chromosome 1 in cervical cancer. Gynecol Oncol. 96:510–515. 2005. View Article : Google Scholar : PubMed/NCBI
9.	Zhou CZ, Qiu GQ, Zhang F, He L and Peng ZH: Loss of heterozygosity on chromosome 1 in sporadic colorectal carcinoma. World J Gastroenterol. 10:1431–1435. 2004.PubMed/NCBI
10.	Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF and Minna JD: Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 60:4894–4906. 2000.PubMed/NCBI
11.	Kleer CG, Bryant BR, Giordano TJ, Sobel M and Merino MJ: Genetic changes in chromosomes 1p and 17p in thyroid cancer progression. Endocr Pathol. 11:137–143. 2000. View Article : Google Scholar : PubMed/NCBI
12.	Schlisio S, Kenchappa RS, Vredeveld LC, et al: The kinesin KIF1beta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev. 22:884–893. 2008. View Article : Google Scholar
13.	Okawa ER, Gotoh T, Manne J, et al: Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas. Oncogene. 27:803–810. 2008. View Article : Google Scholar : PubMed/NCBI
14.	Robbins CM, Tembe WA, Baker A, et al: Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors. Genome Res. 21:47–55. 2011. View Article : Google Scholar : PubMed/NCBI
15.	Sjoblom T, Jones S, Wood LD, et al: The consensus coding sequences of human breast and colorectal cancers. Science. 314:268–274. 2006. View Article : Google Scholar : PubMed/NCBI
16.	Ichimura K, Vogazianou AP, Liu L, et al: 1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas. Oncogene. 27:2097–2108. 2008. View Article : Google Scholar : PubMed/NCBI
17.	Tanas MR, Sboner A, Oliveira AM, et al: Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med. 3:92–98. 2011. View Article : Google Scholar : PubMed/NCBI
18.	Henrich KO, Fischer M, Mertens D, et al: Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients. Clin Cancer Res. 12:131–138. 2006. View Article : Google Scholar : PubMed/NCBI
19.	Zhang H, Zhai Y, Hu Z, et al: Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet. 42:755–758. 2010. View Article : Google Scholar : PubMed/NCBI
20.	Caren H, Fransson S, Ejeskar K, Kogner P and Martinsson T: Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours. Br J Cancer. 97:1416–1424. 2007. View Article : Google Scholar : PubMed/NCBI
21.	Liu Z, Yang X, Li Z, et al: CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ. 18:1174–1183. 2011. View Article : Google Scholar : PubMed/NCBI
22.	He L, He X, Lim LP, et al: A microRNA component of the p53 tumour suppressor network. Nature. 447:1130–1134. 2007. View Article : Google Scholar
23.	Guessous F, Zhang Y, Kofman A, et al: microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle. 9:1031–1036. 2010. View Article : Google Scholar
24.	Cogdell D, Chung W, Liu Y, et al: Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma. Chin J Cancer. 30:247–253. 2011. View Article : Google Scholar : PubMed/NCBI
25.	White PS, Thompson PM, Gotoh T, et al: Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. Oncogene. 24:2684–2694. 2005. View Article : Google Scholar : PubMed/NCBI
26.	Cheung NK and Dyer MA: Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Cancer. 13:397–411. 2013.PubMed/NCBI
27.	Fujita T, Igarashi J, Okawa ER, et al: CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas. J Natl Cancer Inst. 100:940–949. 2008. View Article : Google Scholar : PubMed/NCBI
28.	Milde T, Pfister S, Korshunov A, et al: Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma. Genes Chromosomes Cancer. 48:229–238. 2009. View Article : Google Scholar : PubMed/NCBI
29.	Nagasawa DT, Trang A, Choy W, et al: Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets. Clin Neurol Neurosurg. 115:388–399. 2013. View Article : Google Scholar : PubMed/NCBI
30.	Dong Z, Pang JS, Ng MH, Poon WS, Zhou L and Ng HK: Identification of two contiguous minimally deleted regions on chromosome 1p36.31-p36.32 in oligodendroglial tumours. Br J Cancer. 91:1105–1111. 2004. View Article : Google Scholar : PubMed/NCBI
31.	Alentorn A, Sanson M and Idbaih A: Oligodendrogliomas: new insights from the genetics and perspectives. Curr Opin Oncol. 24:687–693. 2012. View Article : Google Scholar : PubMed/NCBI
32.	McDonald JM, Dunlap S, Cogdell D, et al: The SHREW1 gene, frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration. Cancer Biol Ther. 5:300–304. 2006. View Article : Google Scholar : PubMed/NCBI
33.	Lin N, Di C, Bortoff K, et al: Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma. Mol Cancer Res. 10:208–217. 2012. View Article : Google Scholar : PubMed/NCBI
34.	Ohgaki H and Kleihues P: The definition of primary and secondary glioblastoma. Clin Cancer Res. 19:764–772. 2013. View Article : Google Scholar : PubMed/NCBI
35.	Bharti S, Handrow-Metzmacher H, Zickenheiner S, Zeitvogel A, Baumann R and Starzinski-Powitz A: Novel membrane protein shrew-1 targets to cadherin-mediated junctions in polarized epithelial cells. Mol Biol Cell. 15:397–406. 2004. View Article : Google Scholar : PubMed/NCBI
36.	Le Bivic A, Sambuy Y, Mostov K and Rodriguez-Boulan E: Vectorial targeting of an endogenous apical membrane sialoglyco-protein and uvomorulin in MDCK cells. J Cell Biol. 110:1533–1539. 1990.PubMed/NCBI
37.	Shore EM and Nelson WJ: Biosynthesis of the cell adhesion molecule uvomorulin (E-cadherin) in Madin-Darby canine kidney epithelial cells. J Biol Chem. 266:19672–19680. 1991.PubMed/NCBI
38.	Sako Y, Nagafuchi A, Tsukita S, Takeichi M and Kusumi A: Cytoplasmic regulation of the movement of E-cadherin on the free cell surface as studied by optical tweezers and single particle tracking: corralling and tethering by the membrane skeleton. J Cell Biol. 140:1227–1240. 1998. View Article : Google Scholar : PubMed/NCBI
39.	Aberle H, Butz S, Stappert J, Weissig H, Kemler R and Hoschuetzky H: Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J Cell Sci. 107:3655–3663. 1994.PubMed/NCBI
40.	Jakob V, Schreiner A, Tikkanen R and Starzinski-Powitz A: Targeting of transmembrane protein shrew-1 to adherens junctions is controlled by cytoplasmic sorting motifs. Mol Biol Cell. 17:3397–3408. 2006. View Article : Google Scholar : PubMed/NCBI
41.	Schreiner A, Ruonala M, Jakob V, et al: Junction protein shrew-1 influences cell invasion and interacts with invasion-promoting protein CD147. Mol Biol Cell. 18:1272–1281. 2007. View Article : Google Scholar : PubMed/NCBI
42.	Resch E, Quaiser S, Quaiser T, Schneider G, Starzinski-Powitz A and Schreiner A: Synergism of shrew-1’s signal peptide and transmembrane segment required for plasma membrane localization. Traffic. 9:1344–1353. 2008.PubMed/NCBI
43.	Hiss JA, Resch E, Schreiner A, Meissner M, Starzinski-Powitz A and Schneider G: Domain organization of long signal peptides of single-pass integral membrane proteins reveals multiple functional capacity. PloS One. 3:e27672008. View Article : Google Scholar : PubMed/NCBI
44.	Resch E, Hiss JA, Schreiner A, Schneider G and Starzinski-Powitz A: Long signal peptides of RGMa and DCBLD2 are dissectible into subdomains according to the NtraC model. Mol Biosyst. 7:942–951. 2011. View Article : Google Scholar : PubMed/NCBI
45.	Gottardi CJ and Peifer M: Terminal regions of beta-catenin come into view. Structure. 16:336–338. 2008. View Article : Google Scholar : PubMed/NCBI
46.	Lilien J and Balsamo J: The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell Biol. 17:459–465. 2005. View Article : Google Scholar : PubMed/NCBI
47.	Castellone MD, Teramoto H, Williams BO, Druey KM and Gutkind JS: Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science. 310:1504–1510. 2005. View Article : Google Scholar : PubMed/NCBI
48.	Liu X, Rubin JS and Kimmel AR: Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Curr Biol. 15:1989–1997. 2005. View Article : Google Scholar : PubMed/NCBI
49.	Zeng L, Kang C, Di C, et al: The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBM. Int J Oncol. 44:1243–1251. 2014.
50.	Ernst A, Hofmann S, Ahmadi R, et al: Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clin Cancer Res. 15:6541–6550. 2009. View Article : Google Scholar
51.	Han L, Zhang KL, Zhang JX, et al: AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton re-organization. CNS Neurosci Ther. 20:429–437. 2014. View Article : Google Scholar : PubMed/NCBI